GRAIL INC (GRAL) Stock Overview
USA - NASDAQ:GRAL - US3847471014 - Common Stock
GRAL Key Statistics, Chart & Performance
The current stock price of GRAL is 75.52 USD. In the past month the price increased by 97.08%. In the past year, price increased by 411.65%.
GRAL Latest News, Press Relases and Analysis
GRAL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.36 | 399.63B | ||
| AMGN | AMGEN INC | 13.63 | 160.07B | ||
| GILD | GILEAD SCIENCES INC | 15.28 | 146.79B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.08 | 104.58B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.64B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.63 | 61.09B | ||
| ARGX | ARGENX SE - ADR | 87.98 | 49.92B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.12 | 34.73B | ||
| INSM | INSMED INC | N/A | 34.57B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.08B | ||
| NTRA | NATERA INC | N/A | 24.63B | ||
| BIIB | BIOGEN INC | 8.97 | 21.06B |
Related stock screener links
About GRAL
Company Profile
GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. The company is headquartered in Menlo Park, California and currently employs 1,000 full-time employees. The company went IPO on 2024-06-12. The firm is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.
Company Info
GRAIL INC
1525 O'brien Drive
Menlo Park CALIFORNIA US
Employees: 1000
Phone: 18336942553
GRAIL INC / GRAL FAQ
What is the stock price of GRAIL INC today?
The current stock price of GRAL is 75.52 USD. The price increased by 8.99% in the last trading session.
What is the ticker symbol for GRAIL INC stock?
The exchange symbol of GRAIL INC is GRAL and it is listed on the Nasdaq exchange.
On which exchange is GRAL stock listed?
GRAL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GRAIL INC stock?
10 analysts have analysed GRAL and the average price target is 41.31 USD. This implies a price decrease of -45.3% is expected in the next year compared to the current price of 75.52. Check the GRAIL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GRAIL INC worth?
GRAIL INC (GRAL) has a market capitalization of 2.72B USD. This makes GRAL a Mid Cap stock.
How many employees does GRAIL INC have?
GRAIL INC (GRAL) currently has 1000 employees.
What are the support and resistance levels for GRAIL INC (GRAL) stock?
GRAIL INC (GRAL) has a support level at 32.16. Check the full technical report for a detailed analysis of GRAL support and resistance levels.
Is GRAIL INC (GRAL) expected to grow?
The Revenue of GRAIL INC (GRAL) is expected to grow by 16.28% in the next year. Check the estimates tab for more information on the GRAL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GRAIL INC (GRAL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GRAL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GRAL, evaluating the profitability, health, valuation and growth aspects
- GRAIL INC (GRAL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GRAIL INC (GRAL) Sales and EPS estimates to see what analysts future expectations are.
- GRAIL INC (GRAL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GRAIL INC (GRAL) Insider and Institutional Ownership to learn about the owners and their transactions.
- GRAIL INC (GRAL) Stock Chart to make your own analysis
- GRAIL INC (GRAL) Latest news and press-releases to stay up to date.
Does GRAIL INC (GRAL) stock pay dividends?
GRAL does not pay a dividend.
When does GRAIL INC (GRAL) report earnings?
GRAIL INC (GRAL) will report earnings on 2025-11-11.
What is the Price/Earnings (PE) ratio of GRAIL INC (GRAL)?
GRAIL INC (GRAL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.12).
What is the Short Interest ratio of GRAIL INC (GRAL) stock?
The outstanding short interest for GRAIL INC (GRAL) is 14.39% of its float. Check the ownership tab for more information on the GRAL short interest.
GRAL Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to GRAL. When comparing the yearly performance of all stocks, GRAL is one of the better performing stocks in the market, outperforming 98.76% of all stocks.
GRAL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to GRAL. No worries on liquidiy or solvency for GRAL as it has an excellent financial health rating, but there are worries on the profitability.
GRAL Financial Highlights
Over the last trailing twelve months GRAL reported a non-GAAP Earnings per Share(EPS) of -13.12. The EPS decreased by -15.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.39% | ||
| ROE | -19.14% | ||
| Debt/Equity | 0 |
GRAL Forecast & Estimates
10 analysts have analysed GRAL and the average price target is 41.31 USD. This implies a price decrease of -45.3% is expected in the next year compared to the current price of 75.52.
For the next year, analysts expect an EPS growth of 79.85% and a revenue growth 16.28% for GRAL